Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy

International Archives of Allergy and Immunology

Volumn 147, Issue 3, 2008, Pages 241-245

  Gorska, Lucyna ^a   Chelminska, Marta ^a   Kuziemski, Krzysztof ^a   Skrzypski, Marcin ^a   Niedoszytko, Marek ^a   Damps Konstanska, Iwona ^a   Szymanowska, Amelia ^a   Siemińska, Alicja ^a   Wajda, Beata ^a   Drozdowska, Adrianna ^a   Jutel, Marek ^b   Jassem, Ewa ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

H1 H2 receptor blockers; Hymenoptera; Venom immunotherapy

Indexed keywords

ADRENALIN; ANTAZOLINE; BEE VENOM; CETIRIZINE; DEXAMETHASONE; HYMENOPTERA VENOM; IMMUNOGLOBULIN E ANTIBODY; LORATADINE; RANITIDINE; SALBUTAMOL SULFATE; UNCLASSIFIED DRUG; VENOMENHAL BIENE; VENOMENHAL WESPE; WASP VENOM;

ADOLESCENT; ADULT; ADVERSE OUTCOME; AGED; ALLERGIC REACTION; ANAPHYLAXIS; ANXIETY; ARTICLE; BRONCHOSPASM; BUMBLEBEE; CLINICAL PROTOCOL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; ERYTHEMA; FEMALE; HONEYBEE; HUMAN; HYMENOPTERA; HYPOTENSION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE SWELLING; INSECT ALLERGY; INSECT STING; MAJOR CLINICAL STUDY; MALE; MASTOCYTOSIS; MONOTHERAPY; PAIN; PRIORITY JOURNAL; PRURITUS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SWELLING; SYNCOPE; TACHYCARDIA; TREATMENT DURATION; TREATMENT INDICATION; URTICARIA; URTICARIA PIGMENTOSA; WASP;

ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; ANIMALS; BEE VENOMS; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; HYMENOPTERA; INSECT BITES AND STINGS; MALE; MIDDLE AGED; RISK FACTORS; TREATMENT OUTCOME; WASP VENOMS;

EID: 54249111878     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000142048     Document Type: Article

References (28)

1. Golden DBK: Insect sting allergy and venom immunotherapy: a model and a mystery. J Allergy Clin Immunol 2005;115:439-447.
2. Muller U, Mosbech H, Blaauw P, Dreborg S, Malling HJ, Przybilla B, et al: Emergency treatment of allergic reactions to Hymenoptera stings. Clin Exp Allergy 1991;21:281-288.
3. Charpin D, Birnbaum J, Vervloet D: Epidemiology of hymenoptera allergy. Clin Exp Allergy 1994;24:1010-1015.
4. Novembre E, Cianferoni A, Bernardini R, Veltroni M, Ingargiola A, Lombardi E, et al: Epidemiology of insect venom sensitivity in children and its correlation to clinical and atopic features. Clin Exp Allergy 1998;28:834-838.
5. Annila I: Bee venom allergy. Clin Exp Allergy 2000;30:1682-1687.
6. Nittner-Marszalska M, Liebhart J, Liebhart E, Dor A, Dobek R, Obojski A, et al: Prevalence of Hymenoptera venom allergy and its immunological marker current in adults in Poland. Med Sci Monit 2004;10:324-329.
7. Gawlik R, Nittner-Marszalska M: Allergology in Practice. Łódź, Mediton, 2003.
8. Ross RN, Nelson HS, Finegold J: Effectiveness of specific immunotherapy in the treatment of Hymenoptera venom hypersensitivity. A meta-analysis. Clin Ther 2000;22:351-358.
9. Mosbech H, Muller U: Side-effects of insect venom immunotherapy: results from an EAACI multicenter study. European Academy of Allergology and Clinical Immunology. Allergy 2000;55:1005-1010.
10. Wolf BL, Hamilton RC: Near-fatal anaphylaxis after Hymenoptera venom immunotherapy. J Allergy Clin Immunol 1998;102:527-528.
11. Poli F, Long G, Parmiami S: The safety and efficacy of immunotherapy with aluminum hydroxide-adsorbed venom extract of Vespula spp. An open, retrospective study. Hymenoptera Allergol Immunopathol 2001;29:191-196.
12. Westall GP, Thien FC, Czarny D, O'Hehir RE, Douglas JA: Adverse events associated with rush Hymenoptera venom immunotherapy. Med J Aust 2001;174:227-230.
13. Mueller HL: Insect allergy. Pediatr Clin North Am 1959;6:917-952.
14. Sturm G, Kranke B, Rudolph C, Aberer W: Rush hymenoptera venom immunotherapy: a safe and practical protocol for high-risk patients. J Allergy Clin Immunol 2002;110:928-933.
15. Bonifazi F, Jutel M, Bilo BM, Birnbaum J, Muller U: Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy 2005;60:1459-1470.
16. Laurent J, Smiejan JM, Bloch-Morot E, Herman D: Safety of Hymenoptera venom rush immunotherapy. Allergy 1997;52:94-96.
17. Wenzel J, Meissner-Kraemer M, Bauer R, Bieber T, Gerdsen R: Safety of rush insect venom immunotherapy. The results of a retrospective study in 178 patients. Allergy 2003;58:1176-1179.
18. Brehler R, Wolf H, Kutting B, Schnitker J, Luger T: Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injections. J Allergy Clin Immunol 2000;105:1231-1235.
19. Birnbaum J, Ramadour M, Magnan A, Vervloet D: Hymenoptera ultra-rush venom immunotherapy (210 min): a safety study and risk factors. Clin Exp Allergy 2003;33:58-64.
20. Brockow K, Kiehn M, Riethmuller C, Vieluf D, Berger J, Ring J: Efficacy of antihistamine pretreatment in the prevention of adverse reactions to hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 1997;100:458-463.
21. 2 receptors. Nature 2001;413:420-425.
22. Przybilla B, Ring J, Griesshammer B, Braun-Falco O: Rush hyposensitization with Hymenoptera venoms. Tolerance and results of therapy. Dtsch Med Wochenschr 1987;112:416-424.
23. Berchtold E, Maibach R, Muller U: Reduction of side effects from rush-immunotherapy with honey bee venom by pretreatment with terfenadine. Clin Exp Allergy 1992;22:59-65.
24. Youlten LJ, Atkinson BA, Lee H: The incidence and nature of adverse reactions to injection immunotherapy in bee and wasp allergy. Clin Exp Allergy 1995;25:159-165.
25. Pasaoglu G, Sin BA, Misirligil Z: Rush hymenoptera venom immunotherapy is efficacious and safe. J Investig Allergol Clin Immunol 2006;16:232-238.
26. Jutel M, Akdis M, Blaser K, Akdis CA: Mechanisms of allergen specific immunotherapy - T-cell tolerance and more. Allergy 2006;61:796-807.
27. Muller U, Hari Y, Berchtold E: Premedication with antihistamines may enhance efficacy of specific-allergen immunotherapy. J Allergy Clin Immunol 2001;107:81-86.
28. Mingomataj E, Priftanji A, Qirko E, Dinh QT, Fischer A, Peiser C, et al: Specific immunotherapy in Albanian patients with anaphylaxis to hymenoptera venoms. BMC Dermatol 2002;2:11-16.